DUBLIN--(BUSINESS WIRE)--The "Global Implantable Cardiac Monitors Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Global Implantable Cardiac Monitors Market size is expected to reach $682 million by 2023, rising at a market growth of 7.6% CAGR during the forecast period.
Technological advancements in cardiac monitor devices such as miniaturization & easier implant procedures, growing demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation are some of the key factors that are presently driving the implantable cardiac monitor's market growth. Moreover, growing cases of cardiovascular diseases, remote monitoring systems and growing use of implantable cardiac monitors to monitor epilepsy disorder add to the growth of the market.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on Regions, the Implantable Cardiac Monitors market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Key Topics Covered
1. Market Scope & Methodology
2. Market Overview
3. Global Implantable Cardiac Monitors Market
4. Global Implantable Cardiac Monitors Market by End-user
5. Global Implantable Cardiac Monitors Market by Region
6. Company Profiles
- Abiomed, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Reliant Heart, Inc.
- Astellas Pharma Inc.
- Thoratec Corporation St. (Jude Medical, LLC)
- Agilent Technologies, Inc.
- Berlin Heart GmbH
- Schiller AG
- Jarvik Heart, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/74wpsm/global_682?w=4